Mind + Muscle

technical minds + legal muscle


dig deep

Biosimilars Clarity Coming as FDA Eyes Sandoz Application

  • 07.24.14
  • Jeff Overley
  • IP Law360

Paul A. Calvo, Ph.D. was quoted in this IP Law360 article discussing the first biosimilar application to be accepted by the U.S. Food & Drug Administration (FDA) under the pathway created by the Biologics Price Competition and Innovation Act of 2009 (BPCIA). The acceptance of the biosimilar application from Sandoz Inc. is expected to produce answers about how these products will be utilized in the American market. "It's the first step in actually seeing approval of a biosimilar in the US. I think the word 'finally' comes to mind," said Dr. Calvo.

Subscribers can read the full article at Law360.com.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.